Interpharm Holdings Stock Alpha and Beta Analysis

IPAH Stock  USD 0  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Interpharm Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in Interpharm Holdings over a specified time horizon. Remember, high Interpharm Holdings' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Interpharm Holdings' market risk premium analysis include:
Beta
0.0
Alpha
0.0
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although Interpharm Holdings alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Interpharm Holdings did 0.00  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Interpharm Holdings stock's relative risk over its benchmark. Interpharm Holdings has a beta of 0.00  . The returns on DOW JONES INDUSTRIAL and Interpharm Holdings are completely uncorrelated. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Interpharm Holdings Backtesting, Interpharm Holdings Valuation, Interpharm Holdings Correlation, Interpharm Holdings Hype Analysis, Interpharm Holdings Volatility, Interpharm Holdings History and analyze Interpharm Holdings Performance.
For more detail on how to invest in Interpharm Stock please use our How to Invest in Interpharm Holdings guide.

Interpharm Holdings Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Interpharm Holdings market risk premium is the additional return an investor will receive from holding Interpharm Holdings long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Interpharm Holdings. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Interpharm Holdings' performance over market.
α0.00   β0.00

Interpharm Holdings expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Interpharm Holdings' Buy-and-hold return. Our buy-and-hold chart shows how Interpharm Holdings performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Interpharm Holdings Market Price Analysis

Market price analysis indicators help investors to evaluate how Interpharm Holdings stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Interpharm Holdings shares will generate the highest return on investment. By understating and applying Interpharm Holdings stock market price indicators, traders can identify Interpharm Holdings position entry and exit signals to maximize returns.

Interpharm Holdings Return and Market Media

The median price of Interpharm Holdings for the period between Sat, Sep 27, 2025 and Fri, Dec 26, 2025 is 0.0041 with a coefficient of variation of 0.0. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.0, and mean deviation of 0.0. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About Interpharm Holdings Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Interpharm or other stocks. Alpha measures the amount that position in Interpharm Holdings has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Interpharm Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Interpharm Holdings' short interest history, or implied volatility extrapolated from Interpharm Holdings options trading.

Build Portfolio with Interpharm Holdings

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Interpharm Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Interpharm Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Interpharm Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Interpharm Holdings Stock:
Check out Interpharm Holdings Backtesting, Interpharm Holdings Valuation, Interpharm Holdings Correlation, Interpharm Holdings Hype Analysis, Interpharm Holdings Volatility, Interpharm Holdings History and analyze Interpharm Holdings Performance.
For more detail on how to invest in Interpharm Stock please use our How to Invest in Interpharm Holdings guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Interpharm Holdings technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Interpharm Holdings technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Interpharm Holdings trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...